BG has received consulting fees from Galapagos, AbbVie, and Pfizer; payment for lectures from Galapagos, AbbVie, Janssen, Pfizer, and Takeda; and support for attending meetings from Dr Falk, Takeda, Janssen, and Galapagos. LET has received grants from Janssen Canada, AbbVie Canada, Takeda Canada, Amgen Canada, Pfizer Canada, Fresnenius Kabi Canada, and Eli Lilly Canada; consulting fees from Janssen Canada, AbbVie Canada, Takeda Canada, Amgen Canada, Pfizer Canada, Fresnenius Kabi Canada, Bristol Myers Squibb Canada, Eli Lilly Canada, Viatris Canada, and Celltrion Canada; medical writing support from Bristol Myers Squibb, Pfizer Canada, and AbbVie Canada; and is on the scientific advisory board for GoodCap Pharmaceutical.